Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants

BACKGROUND: The variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) harbor diverse spike (S) protein sequences, which can greatly influence the efficacies of therapeutics. Therefore, it would be of great value to develop neutralizing monoclonal antibodies (mAbs) that can broadly...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Shih-Han, Chen, Wan-Yu, Su, Shih-Chieh, Lin, Hsiu-Ting, Ke, Feng-Yi, Liang, Kang-Hao, Hsu, Fu-Fei, Kumari, Monika, Fu, Chi-Yu, Wu, Han-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774083/
https://www.ncbi.nlm.nih.gov/pubmed/36550570
http://dx.doi.org/10.1186/s12929-022-00891-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774083/
https://www.ncbi.nlm.nih.gov/pubmed/36550570
http://dx.doi.org/10.1186/s12929-022-00891-2

Ejemplares similares